Association of polypharmacy with kidney disease progression in adults with CKD
Clinical Journal of the American Society of Nephrology Nov 20, 2021
Kimura H, Tanaka K, Saito H, et al. - Among Japanese patients with nondialysis-dependent CKD under nephrology care, a high risk of kidney failure, cardiovascular events, and all-cause mortality was observed in relation to use of a high number of medications.
A retrospective analysis of 1,117 Japanese patients with nondialysis-dependent CKD (median age, 66 years; 56% male; median eGFR, 48 ml/min per 1.73 m 2 ) to determine the link between the number of prescribed medications and adverse outcomes.
Relative to the use of fewer than five medications, adjusted hazard ratios related to polypharmacy and hyperpolypharmacy (defined as the regular use of 5–9 and ≥10 medications per day, respectively) were estimated to be 2.28 and 2.83 for renal failure, 1.60 and 3.02 for cardiovascular events, and 1.25 and 2.80 for all-cause death.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries